Abstract
Introduction
In Western countries, the incidence of esophageal adenocarcinoma (EA) and gastric cardia adenocarcinoma (GCA) is increasing. This population-based study describes the incidence of, associated patient risk factors for, and regional variation in EA/GCA in Ontario, Canada.
Methods
All adults with a new diagnosis of EA or GCA between 1972 and 2005 in Ontario were identified. Adjusted annual incidence rates were calculated, and multivariate models were used to identify patient risk factors. Maps were created to explore regional variation.
Results
Over the study period, 8,245 persons were diagnosed with EA/CGA; incidence increased from 1.01 to 3.9 per 100,000. Age (>65 vs. <50 years; rate ratio (RR), 3.4; 95% confidence interval (CI), 2.8–4.1) and comorbidity (highest vs. lowest, RR, 3.5; 95% CI, 2.9–4.2) were most strongly associated with the development of EA/GCA. We found considerable regional variation in the rates of EA/GCA (North West vs. Central region, RR, 6.5; 95% CI, 4.4–9.6). Maps suggested ethnicity may explain some regional variation, and that the current allocation of designated surgical treatment centers for EA/CGA may be suboptimal.
Conclusions
The incidence of EA/GCA is rising dramatically in Ontario. Further investigation of observed regional variation is warranted, particularly for the allocation of cancer health resources.
Similar content being viewed by others
References
Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Adenocarcinomas of the distal esophagus and “gastric cardia” are predominantly esophageal carcinomas. Am J Surg Pathol 2007;31:569-75.
Parfitt JR, Miladinovic Z, Driman DK. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002. Can J Gastroenterol 2006;20:271-6.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
Steffen A, Schulze MB, Pischon T, Dietrich T, Molina E, Chirlaque MD, Barricarte A, Amiano P, Quiros JR, Tumino R, Mattiello A, Palli D, Vineis P, Agnoli C, Misirli G, Boffetta P, Kaaks R, Rohrmann S, Bueno-de-Mesquita HB, Peeters PH, May AM, Spencer EA, Allen NE, Bingham S, Tjonneland A, Halkjaer J, Overvad K, Stegger J, Manjer J, Lindkvist B, Hallmanns G, Stenling R, Lund E, Riboli E, Gonzalez CA, Boeing H. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009;18:2079-89.
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:2.
Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway 1958–1992 Incidence time trend variability according to morphological subtypes and organ subsites. International Journal of Cancer 1997; 71:4.
Sihvo EI, Salmien JT, Ramo OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol. 2000;35:4.
Powell J, McConkey C. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:3.
Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:9.
Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:6.
Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 2007;21:24.
Sundaresan S, Langer B, Oliver T, Schwartz F, Brouwers M, Stern H. Standards for thoracic surgical oncology in a single-payer healthcare system. Ann Thorac Surg 2007;84:693-701.
Anonymous. (2009). “Thoracic Cancer Surgery Standards.” Retrieved January 6, 2010 from http://csqi.cancercare.on.ca/cms/One.aspx?portalId=40955&pageId=41173.
Anonymous. (June 16, 2009). “Local health integration networks: Building a true system.” Retrieved June 24, 2010, from http://www.health.gov.on.ca/transformation/lhin/lhin_mn.html.
Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol 2008;22:143-8.
Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L. Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. Can Med Ass J 2004;171:461-5.
Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. NEJM 1999;341:1359-67.
Wilkins R. Neighbourhood income quintiles derived from Canadian postal codes are apt to be misclassified in rural but not urban areas. In: Health Analysis and Measurement Group and Department of Epidemiology and Community Medicine UoO, ed: Statistics Canada, 2004:31.
Anonymous. “Local Health Integration Networks: Building a True System.” 2007, from http://www.health.gov.on.ca/transformation/lhin/100604/lhin_bul_1_100604.html.
Anonymous. “The Johns Hopkins University ACG Case-Mix System.” Retrieved August 19, 2007, from http://www.acg.jhsph.edu/.
Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population-based oriented measure of ambulatory care case-mix. Medical Care 1991;29:452-472.
Starfield BH, Weiner JP, Mumford LM, Steinwachs DM. Ambulatory care groups: a categorization of diagnoses for research and development. Health Serv Res 1991;26:53-74.
Reid RJ, Roos NP, MacWilliam L, Frohlich N, Black C. Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba. Health Serv Res 2002;37:1345-64.
Reid RJ, MacWilliam L, Verhulst L, Roos N, Atkinson M, Reid RJ, MacWilliam L, Verhulst L, Roos N, Atkinson M. Performance of the ACG case-mix system in two Canadian provinces. Medical Care 2001;39:86-99.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992;45:613-9.
Lord RV, Law MG, Ward RL, Giles GG, Thomas RJ, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol 1998;13:356-62.
Canadian Cancer Society's Steering Committee: Canadian Cancer Statistics 2009. In: Society CC, ed: Government of Canada, 2009:127.
Prasad GA, Bansal A, Sharma P, Wang KK. Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future Directions. Am J Gastroenterol 2010; 105:1490–1502.
Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009;24:729-35.
Kort EJ, Sevensma E, Fitzgerald TL. Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. BMC Gastroenterol 2009;9:47.
Baquet CR, Commiskey P, Mack K, Meltzer S, Mishra SI. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2005;97:1471-8.
Henteleff HJ, Darling G. Canadian Association of General Surgeons Evidence Based Reviews in Surgery. 6. "GERD" as a risk factor for esophageal cancer. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Can J Surg 2003;46:208-10.
Acknowledgements
The authors wish to acknowledge the support of the Institutes for Clinical Evaluative Sciences, the Ontario Ministry of Health and Long-Term Care (MOHLTC), and Cancer Care Ontario (CCO). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, the Ontario MOHLTC, or CCO is intended or should be inferred.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Tinmouth was supported by an Industry-Partnered Canadian Institutes of Health Research New Investigator Award for this project. The industry partner was AstraZeneca Canada, Inc.
Rights and permissions
About this article
Cite this article
Tinmouth, J., Green, J., Ko, YJ. et al. A Population-Based Analysis of Esophageal and Gastric Cardia Adenocarcinomas in Ontario, Canada: Incidence, Risk Factors, and Regional Variation. J Gastrointest Surg 15, 782–790 (2011). https://doi.org/10.1007/s11605-011-1450-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1450-9